Asset Details
Do you wish to reserve the book?
Analysis of clinical features and prognostic factors in patients with hepatic hydrothorax: a single-center study from China
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Analysis of clinical features and prognostic factors in patients with hepatic hydrothorax: a single-center study from China
Do you wish to request the book?
Analysis of clinical features and prognostic factors in patients with hepatic hydrothorax: a single-center study from China
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Analysis of clinical features and prognostic factors in patients with hepatic hydrothorax: a single-center study from China
2022
Overview
Background
The clinical features and factors affecting the prognostic survival of hepatic hydrothorax (HH) are currently unknown.
Methods
We conducted a retrospective cohort study of 131 patients with HH using the Kaplan–Meier method and Cox proportional hazards regression analysis to assess factors influencing the prognosis of HH.
Results
A total of 131 patients were enrolled: the male to female ratio was 80:51 (1.59:1), and the mean age was 52.76 ± 11.88 years. Hepatitis B cirrhosis was the main cause of HH, and abdominal distention and dyspnea were the most common clinical signs. Ascites was present in varying amounts in all patients and was the most common decompensated complication, with pleural effusions mostly seen on the right side (107/131; 82%), followed by the left side (16/131; 12%) and bilateral effusions (8/131; 6%). For overall survival without transplantation, the estimated median survival time was 21 (95% confidence interval [CI]:18–25) months, and survival rates at 6 months, 1 year, and 2 years were 77.2%, 62.4%, and 29.7%, respectively. After controlling for covariates that were associated with liver-related mortality in the univariate analysis, males (hazard ratio [HR]: 1.721, 95% CI: 1.114–2.658,
P
= 0.005) and combined hepatic encephalopathy (HR: 2.016, 95% CI: 1.101–3.693,
P
= 0.001) were found to be associated with an increase in liver-related mortality.
Conclusions
In this cohort of HH patients without liver transplantation, male sex and hepatic encephalopathy were associated with a higher risk of liver-related death.
